Security key
22663K107
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX)
CUSIP: 22663K107
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 105,000,216
- Total 13F shares
- 20,679,487
- Share change
- +3,151,453
- Total reported value
- $303,862,789
- Price per share
- $14.70
- Number of holders
- 55
- Value change
- +$45,411,611
- Number of buys
- 19
- Number of sells
- 28
Report period
Q1 2020
Institutions
55
Top holders
10
CRNX full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Crinetics Pharmaceuticals, Inc. SEC filings
Crinetics Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22663K107
Recent filing periods:
Top shareholders of CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.5%
|
3,633,331
|
$91,160,000 | — | 31 Dec 2019 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.5%
|
2,587,953
|
$64,931,000 | — | 31 Dec 2019 | |
| 5AM Venture Management, LLC |
13F
|
Company |
2.2%
|
2,362,286
|
$59,270,000 | — | 31 Dec 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.9%
|
2,039,282
|
$51,166,000 | — | 31 Dec 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.8%
|
1,875,209
|
$47,049,000 | — | 31 Dec 2019 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.9%
|
947,000
|
$23,760,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.7%
|
732,055
|
$18,367,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.48%
|
504,001
|
$12,646,000 | — | 31 Dec 2019 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.47%
|
488,872
|
$12,266,000 | — | 31 Dec 2019 | |
| Opaleye Management Inc. |
13F
|
Company |
0.25%
|
266,100
|
$6,676,000 | — | 31 Dec 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.22%
|
226,601
|
$5,685,000 | — | 31 Dec 2019 | |
| Burrage Capital Management LLC |
13F
|
Company |
0.2%
|
205,726
|
$5,162,000 | — | 31 Dec 2019 | |
| Polar Capital LLP |
13F
|
Company |
0.19%
|
200,000
|
$5,018,000 | — | 31 Dec 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.19%
|
195,238
|
$4,899,000 | — | 31 Dec 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.17%
|
175,000
|
$4,391,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.14%
|
148,442
|
$3,725,000 | — | 31 Dec 2019 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.13%
|
141,000
|
$3,538,000 | — | 31 Dec 2019 | |
| Novo Holdings A/S |
13F
|
Company |
0.13%
|
135,009
|
$3,387,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
128,409
|
$3,221,000 | — | 31 Dec 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.05%
|
52,947
|
$1,329,000 | — | 31 Dec 2019 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.05%
|
49,172
|
$1,234,000 | — | 31 Dec 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.03%
|
36,108
|
$906,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
35,847
|
$899,000 | — | 31 Dec 2019 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.03%
|
33,865
|
$850,000 | — | 31 Dec 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
28,241
|
$709,000 | — | 31 Dec 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
27,928
|
$701,000 | — | 31 Dec 2019 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
19,100
|
$479,000 | — | 31 Dec 2019 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
18,041
|
$453,000 | — | 31 Dec 2019 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
17,900
|
$449,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
17,407
|
$437,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
17,087
|
$429,000 | — | 31 Dec 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
17,000
|
$427,000 | — | 31 Dec 2019 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
16,600
|
$416,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
12,998
|
$326,000 | — | 31 Dec 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
12,700
|
$319,000 | — | 31 Dec 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
12,698
|
$319,000 | — | 31 Dec 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.01%
|
11,800
|
$296,000 | — | 31 Dec 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
11,198
|
$281,000 | — | 31 Dec 2019 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
10,582
|
$265,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
9,275
|
$232,000 | — | 31 Dec 2019 | |
| Paloma Partners Management Co |
13F
|
Company |
0.01%
|
8,369
|
$210,000 | — | 31 Dec 2019 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.01%
|
7,066
|
$177,000 | — | 31 Dec 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
6,914
|
$173,000 | — | 31 Dec 2019 | |
| HERSHEY TRUST CO |
13F
|
Company |
0.01%
|
6,753
|
$169,000 | — | 31 Dec 2019 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
5,835
|
$146,400 | — | 31 Dec 2019 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0%
|
4,700
|
$118,000 | — | 31 Dec 2019 | |
| METROPOLITAN LIFE INSURANCE CO/NY |
13F
|
Company |
0%
|
4,173
|
$104,701 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
4,020
|
$100,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,759
|
$95,000 | — | 31 Dec 2019 | |
| Jacobi Capital Management LLC |
13F
|
Company |
0%
|
3,000
|
$75,000 | — | 31 Dec 2019 |
Institutional Holders of Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) as of Q1 2020
As of 31 Mar 2020,
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,679,487 shares.
The largest 10 holders included
FMR LLC, Vivo Capital, LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., 5AM Venture Management, LLC, EVENTIDE ASSET MANAGEMENT, LLC, BlackRock Inc., VANGUARD GROUP INC, and JANUS HENDERSON GROUP PLC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
58
Q1 2020 holders
55
Holder diff
-3
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.